These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 18547415)
1. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG Malar J; 2008 Jun; 7():106. PubMed ID: 18547415 [TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C Malar J; 2014 Jan; 13():9. PubMed ID: 24393479 [TBL] [Abstract][Full Text] [Related]
4. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali. Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK Malar J; 2009 Jan; 8():5. PubMed ID: 19128455 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Kabanywanyi AM; Mwita A; Sumari D; Mandike R; Mugittu K; Abdulla S Malar J; 2007 Nov; 6():146. PubMed ID: 17996121 [TBL] [Abstract][Full Text] [Related]
7. Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda. Nawaz F; Nsobya SL; Kiggundu M; Joloba M; Rosenthal PJ J Infect Dis; 2009 Dec; 200(11):1650-7. PubMed ID: 19905933 [TBL] [Abstract][Full Text] [Related]
8. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ Malar J; 2008 Jul; 7():127. PubMed ID: 18620577 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O Malar J; 2007 Jun; 6():80. PubMed ID: 17570848 [TBL] [Abstract][Full Text] [Related]
10. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial. Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818 [TBL] [Abstract][Full Text] [Related]
14. Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children. Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Greenhouse B; Staedke SG; Kamya MR; Dorsey G; Rosenthal PJ PLoS One; 2010 Jul; 5(7):e11759. PubMed ID: 20689585 [TBL] [Abstract][Full Text] [Related]
15. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Fanello CI; Karema C; van Doren W; Van Overmeir C; Ngamije D; D'Alessandro U Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):344-50. PubMed ID: 17005222 [TBL] [Abstract][Full Text] [Related]
16. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554 [TBL] [Abstract][Full Text] [Related]
18. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631 [TBL] [Abstract][Full Text] [Related]
19. Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Toure OA; Assi SB; N'Guessan TL; Adji GE; Ako AB; Brou MJ; Ehouman MF; Gnamien LA; Coulibaly MA; Coulibaly B; Beourou S; Bassinka I; Soumahoro A; Kadjo F; Tano MA Malar J; 2014 Nov; 13():439. PubMed ID: 25409546 [TBL] [Abstract][Full Text] [Related]
20. Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Sundaygar T; Zolia YM; Jones JJ; Comte E; Bruneel A; Branger M; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ Malar J; 2013 Jul; 12():250. PubMed ID: 23866736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]